Price · 10 years
Avg volume
—
—
—
Click the price chart to set a price alert
RARE
Ultragenyx Pharmaceutical Inc.
NASDAQ · EQUITY
RSI (14)
—
—
Click the RSI chart to set an RSI alert
MACD (12, 26, 9)
—
—
A/D Line
—
—
Members of Congress Trading RARE
In the last 12 months, 1 member of Congress disclosed buying RARE, most recently Gil Cisneros (trade on Sep 29, 2026, disclosed Oct 12, 2026).
| Traded | Member | Action | Amount | Disclosed |
|---|---|---|---|---|
| Sep 29, 2026 | Gil Cisneros CA31 | Bought shares | $1K–$15K | Oct 12, 2026 |
| Mar 3, 2026 | Gil Cisneros CA31 | Bought shares | $1K–$15K | Apr 7, 2026 |
| Feb 18, 2026 | Gil Cisneros CA31 | Bought shares | $1K–$15K | Mar 9, 2026 |
Email Me When a Member of Congress Discloses a Trade in RARE
What subscribers were emailed
- Gil Cisneros bought RARE shares $1K–$15K on Sep 29, 2026
Subscribers were emailed this on Oct 12, 2026.
From House and Senate members' STOCK Act disclosures. See which members pick the best stocks on the Congress stock trading leaderboard.
Fund Ownership
How much of each tracked fund's portfolio is in RARE, from their latest 13F filings.
Loading fund ownership…
Financials
Revenue, margins, earnings, and cash flow for RARE, from SEC filings.
Loading financials…
Valuation
A fair-value estimate for RARE you can set a price alert against.
Valuation is built on the same fundamentals feed as the Financials tab. Once it lands, the plan is to let you alert on the gap between price and fair value — not just on a price level.
Research Reports
Decision-first research for RARE, with the full supporting analysis.
No research reports for RARE yet.
Insider Activity
Form 4/5 buys, sells, and grants reported by RARE officers and directors.
Loading insider activity…
RARE on GetMarketAlerts
Ultragenyx Pharmaceutical Inc. (RARE) has a live price chart, RSI(14), moving averages, and volume. Click the chart to set an email alert when price or RSI hits a level.
Indicators to Watch with RARE
Notes
Private to you. Saved automatically as you type.
Sign up to keep notes on RARE.